Tioga Pharmaceuticals
PrivateLast Round
Series B
Apr 10, 2012
Total Funding Raised
$57M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Tioga Pharmaceuticals operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Series B round in April 2012.
Tioga Pharmaceuticals is a pharmaceutical company that develops non-hormonal therapies for women's health, with a lead program for managing vasomotor symptoms associated with menopause.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tioga Pharmaceuticals Comparables
Compare Tioga Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MenoGeniX, Inc. | 87% | |
| Fervent Pharmaceuticals | 87% | |
| Estrigenix Therapeutics | 86% |
For institutional investors. Book with your work email.
Tioga Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 10, 2012 | ||||
| Series A Extension | Feb 17, 2010 | ||||
| Debt | Oct 26, 2009 | ||||
| Debt | May 27, 2009 | ||||
| Series A | Jan 9, 2006 |
For institutional investors. Book with your work email.
Tioga Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Leaf Venture Partners | Series A, Series A Extension |
| Thomas, McNerney & Partners | Series B |
| Genesys Capital | Series B, Series A Extension |
| Forward Ventures | Series A Extension, Series A |
| BB Biotech Ventures | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 54% MoM to 1.1K.
- Jul 25, 2026
Monthly visitors grew 253% MoM, reaching 728.
For institutional investors. Book with your work email.
Tioga Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tioga Pharmaceuticals's valuation, stock price, and market status.
Is Tioga Pharmaceuticals a public or private company?
Tioga Pharmaceuticals is a private company.
What is the current stock price of Tioga Pharmaceuticals?
Tioga Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Tioga Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tioga Pharmaceuticals worth (valuation)?
Valuation information for Tioga Pharmaceuticals is not publicly available.
Can I buy Tioga Pharmaceuticals stock?
Tioga Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tioga Pharmaceuticals's last funding round?
Tioga Pharmaceuticals's most recent funding round was Series B on April 10, 2012.
Who are the main investors in Tioga Pharmaceuticals?
Key investors in Tioga Pharmaceuticals include Thomas, McNerney & Partners, Forward Ventures.
Will Tioga Pharmaceuticals IPO soon?
No public IPO plans have been announced for Tioga Pharmaceuticals.
How can I track Tioga Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Tioga Pharmaceuticals's shares on secondary markets.